Related Experiment Video
Updated: Jun 2, 2026
11:32
Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
Changing needs of community-acquired pneumonia
Julio Alberto Ramirez1, Antonio R Anzueto
1Infectious Diseases, University of Louisville, KY 40202, USA. j.ramirez@louisville.edu
The Journal of Antimicrobial Chemotherapy
|April 13, 2011
Summary
Community-acquired pneumonia (CAP) is a severe lung infection. New antimicrobial agents are needed to combat drug-resistant bacteria like Streptococcus pneumoniae and MRSA, improving patient outcomes.
Area of Science:
- Infectious Diseases
- Microbiology
- Pulmonology
Background:
- Community-acquired pneumonia (CAP) presents significant morbidity and mortality risks.
- Hospitalized patients account for the majority of CAP-related mortality and healthcare costs.
- Identifying risk factors and severity criteria aids in determining appropriate care settings.
Purpose of the Study:
- To highlight the common and emerging pathogens causing CAP.
- To address the challenge of antimicrobial resistance in CAP treatment.
- To emphasize the need for novel antimicrobial agents against resistant strains.
Main Methods:
- Review of common etiological agents of CAP, including typical and atypical pathogens.
- Discussion of the impact of drug-resistant isolates on current therapies.
- Analysis of the critical role of early empirical antimicrobial treatment.
Main Results:
- Common CAP pathogens include Streptococcus pneumoniae, Haemophilus influenzae, and others.
- Emerging drug-resistant strains of Streptococcus pneumoniae and MRSA are limiting treatment effectiveness.
- Viruses, Gram-negative bacilli, and MRSA are also recognized causes of CAP.
Conclusions:
- Effective management of CAP requires addressing antimicrobial resistance.
- Novel antimicrobial agents with activity against resistant S. pneumoniae and MRSA are essential.
- Timely initiation of appropriate antimicrobial therapy is crucial for favorable CAP outcomes.
Related Concept Videos
01:29Pneumonia I: Introduction
Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
01:30Pneumonia I: Introduction
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
01:28Pneumonia IV: Management
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
01:30Pneumonia V: Nursing management and Prevention
Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
01:30Pneumonia III: Complications and Assessment
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
01:14Atypical Pneumonia
Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...